Arnon R, Horwitz R J
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
Curr Opin Immunol. 1992 Aug;4(4):449-53. doi: 10.1016/s0952-7915(06)80037-3.
The use of synthetic peptides as an alternative approach to vaccination is currently being pursued. This is particularly true for viral and parasitic diseases in which no vaccines are yet available, most notably the acquired immune deficiency syndrome.
目前正在探索使用合成肽作为疫苗接种的替代方法。对于尚无疫苗可用的病毒性和寄生虫性疾病,尤其是获得性免疫缺陷综合征,情况更是如此。